Can hospitals use blood tests to catch cancer earlier?

Endeavor Health is studying Exact Sciences' Cancerguard blood test to help see if multi-cancer detection should be deployed widely across hospitals. The five-year study aims to fill gaps in real-world evidence on how these tests perform and how they fit into routine healthcare.

Editor's Pick

Top Story Can Hospitals Use Blood Tests to Catch Cancer Earlier? Endeavor Health Is Trying to Find Out Endeavor Health is studying Exact Sciences' Cancerguard blood test to help see if multi-cancer detection should be deployed widely across hospitals. The five-year study aims to fill gaps in real-world evidence on how these tests perform and how they fit into routine healthcare. Sponsored Restoring Affordability to Employer Health Plans Presented by Imagine360 A new report from Imagine360 makes the case that when it comes to healthcare from self-insured employers, the focus should be more on affordability and less on escalating healthcare costs.  Learn More.

Featured News

PHTI: How Purchasers Can Implement Performance-Based Contracting with Digital Health Solutions PHTI released a playbook guiding purchasers on how to implement performance-based contracts for digital health solutions, focusing on payment models, outcomes and accountability. Startup Fortitude Bio Launches to Beat Drug Resistance in Cancer, Expand ADCs to Autoimmune Disease Fortitude Biomedicines is developing antibody drug conjugates that use targeted protein degraders as their therapeutic payloads. The startup joins a group of degrader ADC (or DAC) developers that includes Bristol Myers Squibb and Pfizer. The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety For many organizations, the workload has become too large for manual review alone. AI and automation are stepping in, not to replace the human element, but to restore focus to it. Individual Coverage Is Reshaping Health Insurance. Agents Are the Key to Making It Work As individual enrollment grows, agents must evolve to meet a more complex, consumer-driven market.

Video   Video: Inside a New Recursion Drug Katie Couric lost her husband to colon cancer in 1998. Nearly 30 years later, colon cancer rates are rising sharply, especially among younger people, and scientists still don't fully understand why. Watch Couric chat with Najat Khan, CEO of Recursion Pharmaceuticals. Recursion is using AI to identify a promising compound that targets the underlying biology of the disease.

Sponsored Omaha ABA Therapy: Comparing the Top Providers Presented by Stride Autism Centers The right provider enables children to gain confidence, learn to express their needs and discover new ways to connect with the world around them. Learn More

Resources

sponsored Esperion Sets Its Sights on New Areas While Maintaining Commitment to Cardiovascular Health Presented by Esperion In a recent interview, Esperion President and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company's expansion into new diseases. Read more

MedCity News • PO Box 901 • New York, NY unsubscribe